Spil Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SPIL, and when can generic versions of SPIL drugs launch?
SPIL has five approved drugs.
There are four US patents protecting SPIL drugs.
There are nine patent family members on SPIL drugs in seven countries and nine supplementary protection certificates in four countries.
Drugs and US Patents for Spil
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Spil | KAPSPARGO SPRINKLE | metoprolol succinate | CAPSULE, EXTENDED RELEASE;ORAL | 210428-003 | Jan 26, 2018 | RX | Yes | No | 9,700,530 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Spil | NIFEDIPINE | nifedipine | TABLET, EXTENDED RELEASE;ORAL | 210838-001 | Apr 16, 2019 | AB2 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Spil | KAPSPARGO SPRINKLE | metoprolol succinate | CAPSULE, EXTENDED RELEASE;ORAL | 210428-003 | Jan 26, 2018 | RX | Yes | No | 9,504,655 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Spil | ASPRUZYO SPRINKLE | ranolazine | GRANULES, EXTENDED RELEASE;ORAL | 216018-002 | Feb 28, 2022 | RX | Yes | Yes | 11,510,878 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Spil Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
European Patent Office | 3166599 | ⤷ Try a Trial |
Japan | 6626492 | ⤷ Try a Trial |
World Intellectual Property Organization (WIPO) | 2016005934 | ⤷ Try a Trial |
Brazil | 112017000468 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Spil Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1109558 | 2008/034 | Ireland | ⤷ Try a Trial | PRODUCT NAME: RANOLAZINE OR A SALT THEREOF; REGISTRATION NO/DATE: EU/1/08/462/001 20080709 |
0984957 | SPC/GB11/013 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: NAPROXEN AND ESOMEPRAZOLE; REGISTERED: UK PL 17901/0263-0001 20101105 |
1411900 | 2011/016 | Ireland | ⤷ Try a Trial | PRODUCT NAME: NAPROXEN AND ESOMEPRAZOLE MODIFIED-RELEASE TABLETS; NAT REGISTRATION NO/DATE: PA0970/060/001 20101221; FIRST REGISTRATION NO/DATE: PL17901/0263-0001 20101105 |
1109558 | 09C0001 | France | ⤷ Try a Trial | PRODUCT NAME: RANOLAZINE; REGISTRATION NO/DATE: EU/1/08/462/001-006 20080714 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.